Abstract
A double-blind cross-over trial of timolol maleate (Timoptol) while routine medical therapy was continued gave the result that pressure was reduced by 3.22 mmHg is compared to placebo and 5.01 compared to pre-timolol levels in 24 patients. There was also a small (1.858 mmHg) drop in pressure in placebo treated eyes, a small and statistically significant drop in resting pulse rate, 76.67 to 71.39/min, and a small but not statistically significant drop in diastolic blood pressure.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Keates E. U. Evaluation of timolol maleate combination therapy in chronic open-angle glaucoma. Am J Ophthalmol. 1979 Sep;88(3 Pt 2):565–571. doi: 10.1016/0002-9394(79)90516-6. [DOI] [PubMed] [Google Scholar]
- Nielsen N. V. Timolol. Hypotensive effect, used alone and in combination for treatment of increased intraocular pressure. Acta Ophthalmol (Copenh) 1978;56(4):504–509. [PubMed] [Google Scholar]
- Radius R. L., Diamond G. R., Pollack I. P., Langham M. E. Timolol. A new drug for management of chronic simple glaucoma. Arch Ophthalmol. 1978 Jun;96(6):1003–1008. doi: 10.1001/archopht.1978.03910050527005. [DOI] [PubMed] [Google Scholar]
- Zimmerman T. J., Kaufman H. E. Timolol, dose response and duration of action. Arch Ophthalmol. 1977 Apr;95(4):605–607. doi: 10.1001/archopht.1977.04450040071009. [DOI] [PubMed] [Google Scholar]
- Zimmerman T. J., Kaufman H. E. Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma. Arch Ophthalmol. 1977 Apr;95(4):601–604. doi: 10.1001/archopht.1977.04450040067008. [DOI] [PubMed] [Google Scholar]